These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32075807)

  • 1. Carbamylated Lipoproteins and Progression of Diabetic Kidney Disease.
    Tan KCB; Cheung CL; Lee ACH; Lam JKY; Wong Y; Shiu SWM
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):359-366. PubMed ID: 32075807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized LDL Is Associated with eGFR Decline in Proteinuric Diabetic Kidney Disease: A Cohort Study.
    Roumeliotis S; Roumeliotis A; Georgianos PI; Stamou A; Manolopoulos VG; Panagoutsos S; Liakopoulos V
    Oxid Med Cell Longev; 2021; 2021():2968869. PubMed ID: 34712380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus.
    Tan KCB; Cheung CL; Lee ACH; Lam JKY; Wong Y; Shiu SWM
    Diabetologia; 2018 May; 61(5):1212-1219. PubMed ID: 29417184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.
    Rahman M; Yang W; Akkina S; Alper A; Anderson AH; Appel LJ; He J; Raj DS; Schelling J; Strauss L; Teal V; Rader DJ;
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1190-8. PubMed ID: 24832097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR identifies atherogenic lipoprotein abnormalities in early diabetic nephropathy that are unrecognized by conventional analysis.
    Al-Shahrouri HZ; Ramirez P; Fanti P; Abboud H; Lorenzo C; Haffner S
    Clin Nephrol; 2010 Mar; 73(3):180-9. PubMed ID: 20178716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 23 and incident CKD in type 2 diabetes.
    Isakova T; Craven TE; Lee J; Scialla JJ; Xie H; Wahl P; Marcovina SM; Byington RP; Wolf M
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):29-38. PubMed ID: 25343949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
    Fernández-Juárez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Lahera V; Casas L; Oliva J;
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1870-6. PubMed ID: 24135218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
    Barr ELM; Barzi F; Hughes JT; Jerums G; Hoy WE; O'Dea K; Jones GRD; Lawton PD; Brown ADH; Thomas M; Ekinci EI; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ
    Diabetes Care; 2018 Apr; 41(4):739-747. PubMed ID: 29367427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
    Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
    Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy.
    Weldegiorgis M; de Zeeuw D; Li L; Parving HH; Hou FF; Remuzzi G; Greene T; Heerspink HJL
    Am J Kidney Dis; 2018 Jan; 71(1):91-101. PubMed ID: 29153995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function.
    Gu L; Huang L; Wu H; Lou Q; Bian R
    Diab Vasc Dis Res; 2017 May; 14(3):221-225. PubMed ID: 28183204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).
    Yokoyama H; Araki S; Haneda M; Matsushima M; Kawai K; Hirao K; Oishi M; Sugimoto K; Sone H; Maegawa H; Kashiwagi A;
    Diabetologia; 2012 Jul; 55(7):1911-8. PubMed ID: 22476921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus.
    Ahn KH; Kim SS; Kim WJ; Kim JH; Nam YJ; Park SB; Jeon YK; Kim BH; Kim IJ; Kim YK
    Korean J Intern Med; 2017 Sep; 32(5):875-882. PubMed ID: 28560862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein Carbamylation and the Risk of ESKD in Patients with CKD.
    Kalim S; Zhao S; Tang M; Rhee EP; Allegretti AS; Nigwekar S; Karumanchi SA; Lash JP; Berg AH
    J Am Soc Nephrol; 2023 May; 34(5):876-885. PubMed ID: 36757153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis.
    Santana MFM; Lira ALA; Pinto RS; Minanni CA; Silva ARM; Sawada MIBAC; Nakandakare ER; Correa-Giannella MLC; Queiroz MS; Ronsein GE; Passarelli M
    Lipids Health Dis; 2020 Sep; 19(1):205. PubMed ID: 32921312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.
    Araki S; Haneda M; Koya D; Kondo K; Tanaka S; Arima H; Kume S; Nakazawa J; Chin-Kanasaki M; Ugi S; Kawai H; Araki H; Uzu T; Maegawa H
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2152-8. PubMed ID: 26563378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
    Lamprea-Montealegre JA; Staplin N; Herrington WG; Haynes R; Emberson J; Baigent C; de Boer IH;
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):47-60. PubMed ID: 31831577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study.
    Gutiérrez OM; Shlipak MG; Katz R; Waikar SS; Greenberg JH; Schrauben SJ; Coca S; Parikh CR; Vasan RS; Feldman HI; Kimmel PL; Cushman M; Bonventre JV; Sarnak MJ; Ix JH
    Am J Kidney Dis; 2022 Jun; 79(6):849-857.e1. PubMed ID: 34752914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.